Key players in Ready-to-Use Injectables
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Fresenius Kabi AG |
fresenius-kabi.com (opens in a new tab) | 231 reports |
| 2 | Baxter International | — | 363 reports |
| 3 |  Hikma Pharmaceuticals PLC |
hikma.com (opens in a new tab) | 132 reports |
| 4 |  BD (Becton, Dickinson) |
bd.com (opens in a new tab) | 759 reports |
| 5 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
Ready-to-Use Injectables reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Ready-to-Use Injectables report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.